AUD 0.01
(-14.29%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 12.8 Million AUD | -23.4% |
2023 | 16.71 Million AUD | 82.21% |
2022 | 9.17 Million AUD | -19.35% |
2021 | 11.37 Million AUD | 17670.2% |
2020 | 64 Thousand AUD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 12.8 Million AUD | -0.17% |
2024 Q2 | 12.82 Million AUD | 25.84% |
2024 Q1 | 10.19 Million AUD | 11.06% |
2024 FY | 12.8 Million AUD | -23.4% |
2024 Q4 | 12.8 Million AUD | 0.0% |
2023 Q1 | 6.4 Million AUD | -30.14% |
2023 Q4 | 9.17 Million AUD | -37.54% |
2023 Q3 | 14.69 Million AUD | 123.81% |
2023 FY | 16.71 Million AUD | 82.21% |
2023 Q2 | 6.56 Million AUD | 2.44% |
2022 FY | 9.17 Million AUD | -19.35% |
2022 Q3 | 9.02 Million AUD | -14.97% |
2022 Q2 | 10.6 Million AUD | 23.34% |
2022 Q1 | 8.6 Million AUD | -24.38% |
2022 Q4 | 9.17 Million AUD | 1.69% |
2021 Q1 | 10.93 Million AUD | 0.0% |
2021 FY | 11.37 Million AUD | 17670.2% |
2021 Q4 | 11.37 Million AUD | 54.65% |
2021 Q3 | 7.35 Million AUD | -55.1% |
2021 Q2 | 16.38 Million AUD | 49.85% |
2020 FY | 64 Thousand AUD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
EZZ Life Science Holdings Limited | 4.22 Million AUD | -202.735% |
Anatara Lifesciences Ltd | 306.84 Thousand AUD | -4072.439% |
Zelira Therapeutics Limited | 9.35 Million AUD | -36.835% |
Biome Australia Limited | 5.37 Million AUD | -138.274% |
Patrys Limited | 691.36 Thousand AUD | -1751.856% |
Orthocell Limited | 22.08 Million AUD | 42.022% |
Imugene Limited | 33.14 Million AUD | 61.371% |
Noxopharm Limited | 1.28 Million AUD | -893.555% |
PYC Therapeutics Limited | 10.18 Million AUD | -25.717% |
Prescient Therapeutics Limited | 2.32 Million AUD | -450.537% |
Proteomics International Laboratories Limited | 1.62 Million AUD | -687.434% |
Cynata Therapeutics Limited | 1.17 Million AUD | -993.295% |
CSL Limited | 27.88 Billion AUD | 99.954% |
Arovella Therapeutics Limited | 2.05 Million AUD | -522.526% |
Bio-Gene Technology Limited | 368.44 Thousand AUD | -3374.888% |
Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 54.457% |
Starpharma Holdings Limited | 8.69 Million AUD | -47.196% |
Nanollose Limited | 465.64 Thousand AUD | -2649.55% |
Memphasys Limited | 5.59 Million AUD | -128.938% |
Invex Therapeutics Ltd | 431.63 Thousand AUD | -2866.218% |
NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -14842.388% |
Amplia Therapeutics Limited | 3.42 Million AUD | -273.616% |
Botanix Pharmaceuticals Limited | 3.73 Million AUD | -243.055% |
Island Pharmaceuticals Limited | 1.04 Million AUD | -1124.445% |
Race Oncology Limited | 1.91 Million AUD | -568.071% |
Nyrada Inc. | 855.63 Thousand AUD | -1396.329% |
Telix Pharmaceuticals Limited | 249.39 Million AUD | 94.866% |
Dimerix Limited | 13.89 Million AUD | 7.845% |
PharmAust Limited | 896.6 Thousand AUD | -1327.948% |
Immutep Limited | 10.97 Million AUD | -16.608% |
Clarity Pharmaceuticals Ltd | 8.33 Million AUD | -53.666% |
Alterity Therapeutics Limited | 5.42 Million AUD | -135.972% |
BTC Health Limited | 203.94 Thousand AUD | -6177.623% |
Acrux Limited | 5.68 Million AUD | -125.129% |
Neuren Pharmaceuticals Limited | 42.76 Million AUD | 70.06% |
Biotron Limited | 737.5 Thousand AUD | -1635.993% |
Tissue Repair Ltd | 1.35 Million AUD | -847.742% |
AdAlta Limited | 3.54 Million AUD | -261.408% |
Radiopharm Theranostics Limited | 44.68 Million AUD | 71.347% |
Hexima Limited | 248.67 Thousand AUD | -5048.625% |
AnteoTech Limited | 4.07 Million AUD | -214.166% |
Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -257.195% |
Recce Pharmaceuticals Ltd | 15.89 Million AUD | 19.444% |
Avecho Biotechnology Limited | 941.54 Thousand AUD | -1259.803% |
Actinogen Medical Limited | 1.61 Million AUD | -692.58% |
Immuron Limited | 2.84 Million AUD | -350.73% |
Argenica Therapeutics Limited | 2.42 Million AUD | -427.588% |